Dr Robert Foldes

Dr Robert Foldes has been appointed president and CEO of Cytochroma Inc, an early-stage developer of drug compounds based on cytochrome P450 enzymzes. Foldes joins the Kingston ON-based firm after a stint at Toronto's Hospital for Sick Children, where he served as director of research business development and established its intellectual property and commercialization development office. Prior to that, he spent seven years at Allelix Biopharmaceuticals Inc. Foldes received his BSc from the Univ of Toronto, a PhD in pharmacology at the Univ of Nebraska Medical Centre and an MBA at York Univ. At Cytochroma, Foldes will develop new business opportunities and commercialize its proprietary technology....